Delivery Order SPE2DE24D0013-SPE2D626F01FT
- Not listed
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a $34,000 firm fixed-price delivery order (Contract 4570371726, XPRS4PLEX-10) by the Defense Logistics Agency Medical Supply Chain on December 29, 2025, with an ultimate completion date of January 6, 2026. This delivery order, which carries no set-aside designation, is issued under Cepheid's existing Indefinite Delivery Contract with the Department of Veterans Affairs Veterans Integrated Service Network (VISN) 17, valued at...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $2,760 by the Defense Logistics Agency Medical Supply Chain on January 9, 2026, with an ultimate completion date of January 16, 2026. This is a child contract under a larger indefinite delivery vehicle, utilizing a firm fixed-price structure with no set-aside designation. The delivery order, identified as XPRSTREPA-10, pertains to diagnostic reagents and test kits for Cepheid's GeneXpert molecular...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $28,875 by the Defense Logistics Agency Medical Supply Chain on December 10, 2025, with an ultimate completion date of December 17, 2025. This delivery order, designated XPRS-COV2-10, was issued with no set-aside designation and represents procurement of diagnostic testing supplies under Cepheid's existing Indefinite Delivery Contract framework with the Department of Veterans Affairs....
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $95,200 by the Defense Logistics Agency Medical Supply Chain on January 8, 2026, with an ultimate completion date of January 15, 2026. This firm fixed-price delivery order, designated XPRS4PLEX-10, is issued without a set-aside designation and represents a child contract under one of Cepheid's larger indefinite delivery vehicle agreements with the Department of Veterans Affairs. The delivery order...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $1,800 on January 6, 2026, under a Defense Logistics Agency Medical Supply Chain contract. This firm fixed-price delivery order, with an ultimate completion date of January 13, 2026, represents a continuation of Cepheid's established role as a primary federal supplier of molecular diagnostic systems and reagents. The award carries no set-aside designation, reflecting Cepheid's competitive positioning...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a $4,620 firm fixed-price delivery order by the Defense Logistics Agency Medical Supply Chain on January 13, 2026, with an ultimate completion date of January 21, 2026. This delivery order, designated XPRS-COV2-10, represents a child contract issued under Cepheid's broader Indefinite Delivery Contract with the Department of Veterans Affairs Veterans Integrated Service Network (VISN) 17, valued at $6.7 million through December...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a $6,800 firm fixed-price delivery order (Contract No. 4570311585, XPRS4PLEX-10) by the Defense Logistics Agency's Medical Supply Chain on December 16, 2025, with an ultimate completion date of December 23, 2025. This delivery order, which carries no set-aside designation, is issued under a larger Indefinite Delivery Contract (IDC) established with the Department of Veterans Affairs VISN 17, valued at $6.7 million through December...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a $40,946.80 firm fixed-price delivery order by the Defense Logistics Agency Medical Supply Chain on December 2, 2025, with an ultimate completion date of December 9, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, pertains to molecular diagnostic reagents and test cartridges for detecting COVID-19, influenza, and respiratory syncytial virus using Cepheid's GeneXpert diagnostic platform. The contract carries no...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a $2,040 delivery order (Contract No. 4570200483, XPRS4PLEX-10) by the Defense Logistics Agency Medical Supply Chain on December 5, 2025, with an ultimate completion date of December 12, 2025. This firm fixed-price delivery order, which carries no set-aside designation, is for molecular diagnostic testing supplies and reagents for the GeneXpert diagnostic platform. The award represents a continuation of Cepheid's established...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a $7,480 firm fixed-price delivery order by the Defense Logistics Agency Medical Supply Chain on January 7, 2026, with an ultimate completion date of January 14, 2026. This delivery order, valued at the ceiling amount, is issued under Cepheid's larger Indefinite Delivery Contract with the Department of Veterans Affairs Veterans Integrated Service Network 17, which is valued at $6.7...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F01FTDelivery Order
Cepheid Inc., headquartered in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $20,350 by the Defense Logistics Agency Medical Supply Chain on January 12, 2026, with an ultimate completion date of January 20, 2026. This delivery order, designated as XPRS4PLEX-10, represents a child contract under Cepheid's larger Indefinite Delivery Contract vehicle with the Veterans Health Administration VISN 6, valued at $32.8 million and extending through September 30, 2030. The award carries no set-aside designation, reflecting Cepheid's competitive positioning as a primary federal supplier of molecular diagnostic solutions. The contract is for diagnostic reagents and test kits designed for the GeneXpert diagnostic platform, which detects multiple respiratory pathogens and other infectious diseases critical to federal healthcare operations. Cepheid specializes in advanced molecular diagnostic systems and has established itself as a core supplier across multiple federal healthcare agencies, including the Department of Veterans Affairs, Indian Health Service, Defense Health Agency, and U.S. Coast Guard. The company's GeneXpert platform and associated testing capabilities support rapid molecular diagnostics for COVID-19, influenza, respiratory syncytial virus, tuberculosis, and other infectious diseases. The modest ceiling value of this delivery order reflects a routine procurement of testing reagents and cartridges to support ongoing laboratory operations at VA medical facilities, consistent with Cepheid's extensive history of supplying diagnostic supplies through firm fixed-price contracting vehicles across the federal healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.4k | 1/11/26 |